BioPharm International
BioPharm International-08-01-2004
Volume: 17
Issue: 8
BioPharm International-08-15-2004
Volume: 2004 Supplement
Issue: 2
BioPharm International-07-01-2004
Volume: 17
Issue: 7
BioPharm International-06-01-2004
Volume: 17
Issue: 6
BioPharm International-05-01-2004
Volume: 17
Issue: 5
BioPharm International-04-01-2004
Volume: 17
Issue: 4
BioPharm International-03-01-2004
Volume: 17
Issue: 3
BioPharm International-02-01-2004
Volume: 17
Issue: 2
BioPharm International-02-15-2004
Volume: 2004 Supplement
Issue: 1
BioPharm International-01-01-2004
Volume: 17
Issue: 1
BioPharm International-12-01-2003
Volume: 16
Issue: 12
BioPharm International-11-15-2003
Volume: 2003 Supplement
Issue: 4
BioPharm International-11-01-2003
Volume: 16
Issue: 11
BioPharm International-10-01-2003
Volume: 16
Issue: 10
BioPharm International-09-01-2003
Volume: 16
Issue: 9
BioPharm International-09-15-2003
Volume: 2003 Supplement
Issue: 3
BioPharm International-08-01-2003
Volume: 16
Issue: 8
BioPharm International-07-01-2003
Volume: 16
Issue: 7
BioPharm International-07-15-2003
Volume: 2003 Supplement
Issue: 2
BioPharm International-06-01-2003
Volume: 16
Issue: 6
BioPharm International-06-02-2003
Volume: 2003 Supplement
Issue: 1
BioPharm International-05-01-2003
Volume: 16
Issue: 5
BioPharm International-04-01-2003
Volume: 16
Issue: 4
BioPharm International-03-01-2003
Volume: 16
Issue: 3
BioPharm International-02-01-2003
Volume: 16
Issue: 2
BioPharm International-01-01-2003
Volume: 16
Issue: 1
BioPharm International-12-15-2002
Volume: 15
Issue: 1
BioPharm International-11-01-2002
Volume: 15
Issue: 11
BioPharm International-10-01-2002
Volume: 15
Issue: 10
BioPharm International-09-01-2002
Volume: 15
Issue: 9
Advertisement
Advertisement
Trending on BioPharm International
1
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
2
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
3
Top BP Videos of 2025: An Intersection of AI, Innovation, and Compliance
4
Conjugation and Regulation Challenges for Advanced Molecules: Part Two of Three with Abzena
5